Literature DB >> 8980942

Decreased substance P levels in rectal biopsies from patients with slow transit constipation.

K Tzavella1, R L Riepl, A G Klauser, W A Voderholzer, N E Schindlbeck, S A Müller-Lissner.   

Abstract

OBJECTIVE: Previous studies in patients with chronic constipation found abnormalities in the nervous tissue of the large intestine, predominantly in the muscularis externa. Since there is evidence that the nervous system of mucosa and submucosa is also involved in the control of colonic motility we investigated the contents of vasoactive intestinal polypeptide (VIP), somatostatin and substance P in rectal biopsies of patients with slow colonic transit constipation. DESIGN AND METHODS: Twenty-two patients (17 females, 5 males) with chronic slow transit constipation (oro-anal transit with radio-opaque markers on high fibre diet > 70 h) and long-term use of laxatives, and 20 controls (12 females, 8 males) with no history of constipation, were included in this study. Large rectal biopsy specimens including the submucosa were obtained from 5 cm above the dentate line and frozen in liquid nitrogen. After microdissection of the biopsies into mucosa and submucosa the neuropeptides were extracted by boiling and homogenizing the tissue in acetic acid and determined using validated radioimmunoassays.
RESULTS: Patients with slow transit constipation showed, compared to healthy controls, significantly lower levels of the excitatory neurotransmitter substance P in the mucosa and submucosa of rectal biopsies. There was no difference between the two groups concerning the levels of the inhibitory neurotransmitters, VIP and somatostatin.
CONCLUSION: Slow transit constipation is associated with abnormalities of the substance P content of the enteric nervous system of mucosa and submucosa. This seems not to be related to chronic laxative use, since anthranoids cause a reduction in the levels of inhibitory neurotransmitters (VIP, somatostatin), but not of substance P, in the rat colon.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8980942     DOI: 10.1097/00042737-199612000-00014

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  27 in total

Review 1.  Management of opioid-induced bowel dysfunction in cancer patients.

Authors:  Antonio Cesar Tamayo; Paola Andrea Diaz-Zuluaga
Journal:  Support Care Cancer       Date:  2004-09       Impact factor: 3.603

Review 2.  Slow transit constipation: a functional disorder becomes an enteric neuropathy.

Authors:  Gabrio Bassotti; Vincenzo Villanacci
Journal:  World J Gastroenterol       Date:  2006-08-07       Impact factor: 5.742

Review 3.  Mechanisms of Action of Probiotics and the Gastrointestinal Microbiota on Gut Motility and Constipation.

Authors:  Eirini Dimidi; Stephanos Christodoulides; S Mark Scott; Kevin Whelan
Journal:  Adv Nutr       Date:  2017-05-15       Impact factor: 8.701

Review 4.  The physiology of human defecation.

Authors:  Somnath Palit; Peter J Lunniss; S Mark Scott
Journal:  Dig Dis Sci       Date:  2012-02-26       Impact factor: 3.199

Review 5.  The pathophysiology of chronic constipation.

Authors:  Christopher N Andrews; Martin Storr
Journal:  Can J Gastroenterol       Date:  2011-10       Impact factor: 3.522

Review 6.  [Motility disorders of the colon].

Authors:  S Müller-Lissner
Journal:  Internist (Berl)       Date:  2015-06       Impact factor: 0.743

7.  Do elevated plasma vasoactive intestinal polypeptide (VIP) levels cause small intestinal motor disturbances in humans?

Authors:  Jutta Keller; Jan C Mueller-Wolf; Keihan Ahmadi-Simab; Christiane Fibbe; Ulrich Rosien; Peter Layer
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

8.  Medical treatment of constipation.

Authors:  Jonathan D Siegel; Jack A Di Palma
Journal:  Clin Colon Rectal Surg       Date:  2005-05

9.  Medical management of constipation.

Authors:  Meredith Portalatin; Nathaniel Winstead
Journal:  Clin Colon Rectal Surg       Date:  2012-03

10.  Cellular and molecular basis of chronic constipation: taking the functional/idiopathic label out.

Authors:  Gabrio Bassotti; Vincenzo Villanacci; Dragos Creţoiu; Sanda Maria Creţoiu; Gabriel Becheanu
Journal:  World J Gastroenterol       Date:  2013-07-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.